Intellectual Property India Publishes Patent Application for 'Synthetic Primase-Polymerase And Uses Thereof' Filed by Tyris Therapeutics, S. L.

MUMBAI, India, Feb. 28 -- Intellectual Property India has published a patent application (202517003453 A) filed by Tyris Therapeutics, S. L., Valencia, Spain, on Jan. 15, for 'synthetic primase-polymerase and uses thereof.'

Inventor(s) include Perez Jimenez, Raul; Quesada Ganuza, Ane; Alonso Lerma, Borja; and Oyarzabal Santamarina, Julen.

The application for the patent was published on Feb. 28, under issue no. 09/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a polypeptide comprising a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3, or a variant thereof at least 90% identical to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3. The inven...